Ncardia will attend this year's SLAS Europe Conference & Exhibition (Brussels, BE)
Location: Brussels, BE
Date: 27 - 29 June (Hamamatsu FDSS Workshop 28 June)
Members of the Ncardia team will be in attendance at this year's SLAS Europe Conference & Exhibition.
Dr. Mieke Doornbos, Product Marketing Manager, and Dr. Stefan Braam, CEO of Ncardia, would be delighted to meet you to tell you more about the latest developments with Ncardia's hiPSC-derived cell portfolio, services, and applications.
Stefan will give the following presentation, which showcases Ncardia's hiPSC-derived cardiomyocytes:
- "iPSC-derived cardiomyocytes; how validation in cardiac safety pharmacology opens the door for new applications in drug discovery and development"
Hamamatsu FDSS Workshop (28 June)
Furthermore, Dr. Dietmar Hess, Senior Applications Specialist, and Alexandre Fouassier, Business Development Manager Southern Europe, will take part in the Hamamatsu FDSS Workshop on the second day of the SLAS Europe meeting (28 June), where they will give the following presentations:
- "CNS.4U®: A powerful tool in seizure liability studies"
- "Overview of Ncardia products and services - human iPSC-derived cardiac cells"
We are looking forward to meeting you in Brussels!
You can download a copy of this flyer here